Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...
1d
Received 3 Rare Pediatric Disease Designations (RPDD) from FDA for each of 3 potential therapies for 3 different rare inherited retinopathies ...
Analysts did not seem very concerned by the treatment-related serious adverse event, noting that NGN-401 was well-tolerated ...
Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...
Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, ...
Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, ...
Dyno Therapeutics has recently announced the formation of a new strategic partnership with Swiss pharma giant Roche to ...
Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...
With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback